Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Advancing knowledge in the field of heart failure management
The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.
The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.
Acute heart failure after non‐cardiac surgery: incidence, phenotypes, determinants and outcomes
Author(s):
Danielle M. Gualandro,
Christian Puelacher,
Michelle S. Chew,
Henrik Andersson,
Giovanna Lurati Buse,
Noemi Glarner,
Daria Mueller,
Francisco A.M. Cardozo,
Katrin Burri‐Winkler,
Constantin Mork,
Desiree Wussler,
Samyut Shrestha,
Isabelle Heidelberger,
Mikael Fält,
Reka Hidvegi,
Daniel Bolliger,
Andreas Lampart,
Luzius A. Steiner,
Stefan Schären,
Christoph Kindler,
Lorenz Gürke,
Daniel Rikli,
Didier Lardinois,
Stefan Osswald,
Andreas Buser,
Bruno Caramelli,
Christian Mueller,
for the BASEL‐PMI Investigators
07 Feb 2023
Effect of patisiran on stroke volume in hereditary transthyretin‐mediated amyloidosis: insights from pressure–volume analysis of the APOLLO study
Author(s):
Hannah R. Rosenblum,
Jan M. Griffin,
Masatoshi Minamisawa,
Narayana Prasad,
John Vest,
Matthew T. White,
Scott D. Solomon,
Daniel Burkhoff,
Mathew S. Maurer
07 Feb 2023
Interleukin‐6 in acute heart failure: it does work, but how much? Letter regarding the article ‘Quantifying inflammation using interleukin‐6 for improved phenotyping and risk stratification in acute heart failure’
Author(s):
Sibo Wang,
Jiateng Sun,
Liansheng Wang
07 Feb 2023
Letter regarding the article ‘Little at a time: trying to understand the battery of benefits of sodium–glucose cotransporter 2 inhibitors in heart failure’
Author(s):
Camilla Fuchs Andersen,
Andreas Glenthøj,
Jesper Jensen
Our mission: To reduce the burden of cardiovascular disease.
Our mission: To reduce the burden of cardiovascular disease.